|
1 |
High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)
Kirkeby, Agnete. - Konstanz : Bibliothek der Universität Konstanz, 2009
|
|
|
2 |
Ensuring the right to food for indigenous children: a case study of stakeholder perspectives on policy options to ensure the rights of tamariki Māori to healthy food
Enthalten in International journal for equity in health Bd. 20, 27.2.2021, Nr. 1, date:12.2021: 1-13
|
|
|
|
3 |
Erratum to: Methods for evaluating medical tests and biomarkers
Enthalten in Diagnostic and prognostic research Bd. 1, 30.3.2017, Nr. 1, date:12.2017: 1-5
|
|
|
|
4 |
Exploring the accessibility of primary health care data in Europe's COVID-19 response: developing key indicators for managing future pandemics (Eurodata study)
Enthalten in BMC primary care Bd. 25, 20.6.2024, Nr. 1, date:12.2024: 1-10
|
|
|
|
5 |
Key outcomes for reporting in studies of pregnant women with multiple long-term conditions: a qualitative study
Enthalten in BMC pregnancy and childbirth Bd. 23, 1.8.2023, Nr. 1, date:12.2023: 1-15
|
|
|
|
6 |
Methods for Evaluating Medical Tests and Biomarkers
Enthalten in Diagnostic and prognostic research Bd. 1, 16.2.2017, Nr. 1, date:2.2017: 1-34
|
|
|
|
7 |
Myositis ossificans circumscripta after surgery and radiotherapy and during sunitinib treatment: a case report
Enthalten in Journal of medical case reports Bd. 16, 7.12.2022, Nr. 1, date:12.2022: 1-6
|
|
|
|
8 |
Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats
Enthalten in BMC complementary medicine and therapies Bd. 21, 31.12.2021, Nr. 1, date:12.2021: 1-11
|
|
|
|
9 |
Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019
Enthalten in BMC medicine Bd. 21, 16.1.2023, Nr. 1, date:12.2023: 1-13
|
|
|
|
10 |
The development of a core outcome set for studies of pregnant women with multimorbidity
Enthalten in BMC medicine Bd. 21, 21.8.2023, Nr. 1, date:12.2023: 1-15
|
|
Administration
